Department of Pathology
Virginie Verkarre has not added Biography.
If you are Virginie Verkarre and would like to personalize this page please email our Author Liaison for assistance.
[Immunotherapy in uropathology].
Annales de pathologie Feb, 2017 | Pubmed ID: 28111042
Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.
Journal of hepatology Jan, 2008 | Pubmed ID: 17998147
[Gastrointestinal diseases in primary immunodeficiency disorders].
Gastroenterologie clinique et biologique Oct, 2007 | Pubmed ID: 18166864
IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis.
The Journal of clinical investigation Jun, 2010 | Pubmed ID: 20440074
A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients.
Journal of immunotherapy (Hagerstown, Md. : 1997) Nov-Dec, 2010 | Pubmed ID: 20948437
Diagnostic yield of capsule endoscopy in refractory celiac disease.
The American journal of gastroenterology Oct, 2012 | Pubmed ID: 22964554
Renal malacoplakia: Case report of a differential diagnosis for renal cell carcinoma.
The American journal of case reports , 2012 | Pubmed ID: 23569483
Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association Apr, 2014 | Pubmed ID: 24316103
Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
Orphanet journal of rare diseases Oct, 2014 | Pubmed ID: 25519458
Molecular subtypes of clear cell renal cell carcinoma are associated with sunitinib response in the metastatic setting.
Clinical cancer research : an official journal of the American Association for Cancer Research Mar, 2015 | Pubmed ID: 25583177
Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2015 | Pubmed ID: 25688160
High milk consumption does not affect prostate tumor progression in two mouse models of benign and neoplastic lesions.
PloS one , 2015 | Pubmed ID: 25938513
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies.
The Lancet. Oncology Jun, 2015 | Pubmed ID: 25979595
Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy.
PloS one , 2015 | Pubmed ID: 26101883
Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study.
Clinical transplantation Aug, 2016 | Pubmed ID: 27251769
Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib.
BJU international Dec, 2016 | Pubmed ID: 27417418
[Innovations in medical undergraduate pathology education: The Paris Descartes medicine faculty experience].
Annales de pathologie Aug, 2016 | Pubmed ID: 27475003
Unique Transcriptomic Profile of Collecting Duct Carcinomas Relative to Upper Tract Urothelial Carcinomas and other Kidney Carcinomas.
Scientific reports Aug, 2016 | Pubmed ID: 27484008
Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma.
Cancer research Mar, 2017 | Pubmed ID: 27872087
Vitamin D3 Prevents Calcium-Induced Progression of Early-Stage Prostate Tumors by Counteracting TRPC6 and Calcium Sensing Receptor Upregulation.
Cancer research Jan, 2017 | Pubmed ID: 27879271
Pathological heterogeneity in sporadic synchronous renal tumors: Is the histological concordance predictable?
Urologic oncology Jan, 2018 | Pubmed ID: 28993058
Pro-angiogenic gene expression is associated with better outcome on sunitinib in metastatic clear-cell renal cell carcinoma.
Acta oncologica (Stockholm, Sweden) Nov, 2017 | Pubmed ID: 29095068
Clémence Granier1,
Emeline Vinatier2,3,4,
Elia Colin2,3,
Marion Mandavit2,3,
Charles Dariane2,3,5,
Virginie Verkarre6,
Lucie Biard7,
Rami El Zein2,
Corinne Lesaffre2,
Isabelle Galy-Fauroux2,
Hélène Roussel2,3,6,
Eléonore De Guillebon8,
Charlotte Blanc2,3,
Antonin Saldmann4,
Cécile Badoual2,6,
Alain Gey*,4,
Éric Tartour*,2,4
1PARCC-INSERM U970, Université Paris Descartes,
2INSERM U970, Université Paris Descartes,
3, Equipe Labellisée Ligue Contre le Cancer,
4Department of Immunology, Hopital Européen Georges Pompidou,
5Department of Medical Urology, Hopital Européen Georges Pompidou,
6Department of Pathology, Hopital Européen Georges Pompidou,
7, Université Paris Diderot Paris 7,
8Department of medical oncology, Hopital Européen Georges Pompidou
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유